Alignment Healthcare (ALHC)
(Real Time Quote from BATS)
$16.33 USD
-0.35 (-2.10%)
Updated Sep 18, 2025 01:08 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ALHC 16.33 -0.35(-2.10%)
Will ALHC be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ALHC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ALHC
Are Medical Stocks Lagging Akebia Therapeutics (AKBA) This Year?
Clover Health Pre-Q2 Earnings Analysis: Buy, Sell or Hold the Stock?
ALHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Alignment Healthcare (ALHC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Alignment Healthcare (ALHC) Q2 Earnings and Revenues Surpass Estimates
Alignment Healthcare (ALHC) Upgraded to Buy: Here's What You Should Know
Other News for ALHC
ALHC forms NR7 on September 17
U.S. health insurers pledge continuing coverage of COVID shots ahead of ACIP meeting
Director Cashes In on Alignment Healthcare Stock Sale
GENERAL ATLANTIC, L.P. Reduces Stake in Alignment Healthcare Inc
20 Day Moving Average Support appears for ALHC after 1.35% move